We show here that the varicella-zoster virus (VZV) open reading frame 66 (ORF66) protein kinase is one mechanism employed to reduce class I major histocompatibility complex (MHC-I) surface expression in VZV-infected cells. Cells expressing enhanced green fluorescent protein-tagged functional and inactivated ORF66 (GFP-66 and GFP-66kd) from replication-defective adenovirus vectors revealed that ORF66 reduced MHC-I surface levels in a manner dependent on kinase activity. Cells infected with recombinant VZV expressing GFP-66 exhibited a significantly greater reduction in MHC-I surface expression than that observed in cells infected with VZV disrupted in GFP-66 expression. MHC-I maturation was delayed in its transport from the endoplasmic reticulum through the Golgi in both adenovirus-transduced cells expressing only GFP-66 and in VZV-infected cells expressing high levels of GFP-66, and this was predominantly kinase dependent. MHC-I levels were reduced in VZV-infected cells, and analyses of intracellular MHC-I revealed accumulation of folded MHC-I in the Golgi region, irrespective of ORF66 expression. Thus, the ORF66 kinase is important for VZV-mediated MHC-I downregulation, but additional mechanisms also may be involved. Analyses of the VZV ORF9a protein, the ortholog of the bovine herpesvirus 1 transporter associated with antigen processing inhibitor UL49.5 revealed no effects on MHC-I. These results establish a new role for viral protein kinases in immune evasion and suggest that VZV utilizes unique mechanisms to inhibit antigen presentation.Varicella-zoster virus (VZV) is the human-restricted member of the herpesvirus subfamily Alphaherpesvirinae and causes chicken pox upon primary infection and herpes zoster (shingles) following reactivation from a prolonged period of neuronal latency in the sensory ganglia. Based on the current model of pathogenesis (38), efficient dissemination, disease, and establishment of latency within the infected host requires VZV growth in multiple cell types. Following inhalation, VZV is spread to epidermal sites of replication by a T-lymphocyteassociated viremia. Infection likely occurs in the tonsils, with VZV preferentially infecting memory CD4 ϩ T lymphocytes (39). These T cells can home to and mediate infection of human skin allografts in the severe combined immunodeficient (SCID)-hu model of VZV infection (40). In humans, skin lesions occur 10 to 21 days after the initial inoculation, and VZV DNA is detected in peripheral blood mononuclear cells during primary infection (13,45). VZV accesses axons of innervating sensory neurons in the skin and establishes a lifelong latent infection in neurons of the dorsal root ganglia. In contrast with latency of the closely related herpes simplex virus type 1 (HSV-1), VZV latency is characterized by persistent transcription, and possibly expression, of several viral lytic genes, including open reading frames (ORFs) 4, 21, 29, 62, 63, and 66 (10,